眼科和视光学的私募股权投资：2012 年至 2021 年的时间序列分析。
Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021.
机构信息
Department of Ophthalmology, New York University, Grossman School of Medicine, New York, New York.
Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York Eye and Ear Infirmary of Mount Sinai, New York, New York.
出版信息
Digit J Ophthalmol. 2023 Mar 31;29(1):1-8. doi: 10.5693/djo.01.2022.10.004. eCollection 2023.
PURPOSE
To identify temporal and geographic trends in private equity (PE)-backed acquisitions of ophthalmology and optometry practices in the United States from 2012 to 2021.
METHODS
In this cross-sectional time series, acquisition data from 10/21/2019 to 9/1/2021 and previously published data from 1/1/2012 to 10/20/2019 were analyzed. Acquisition data were compiled from 6 financial databases, 5 industry news outlets, and publicly available press releases. Linear regression models were used to compare rates of acquisition. Outcomes included number of total acquisitions, practice type, locations, provider details, and geographic footprint.
RESULTS
A total of 245 practices associated with 614 clinical locations and 948 ophthalmologists or optometrists were acquired by 30 PE-backed platform companies between 10/21/2019 and 9/1/2021. Of 30 platform companies, 18 were new vis-à-vis our prior study. Of these acquisitions, 127 were comprehensive practices, 29 were retina practices, and 89 were optometry practices. From 2012 to 2021, monthly acquisitions increased by 0.947 acquisitions per year ( < 0.001*). Texas, Florida, Michigan, and New Jersey were the states with the greatest number of PE acquisitions, with 55, 48, 29, and 28 clinic acquisitions, respectively. Average monthly PE acquisitions were 5.71 per month from 1/1/2019 to 2/29/2020 (pre-COVID), 5.30 per month from 3/1/2020 to 12/31/2020 (COVID pre-vaccine [ = 0.81]), and 8.78 per month from 1/1/2021 to 9/1/2021 (COVID post-vaccine [ = 0.20]).
CONCLUSIONS
PE acquisitions increased during the period 2012-2021 as companies continue to utilize regionally focused strategies for acquisitions.
目的
从 2012 年至 2021 年，确定美国私人股本（PE）支持的眼科和验光实践收购的时间和地理趋势。
方法
在这项横断面时间序列研究中，分析了 2019 年 10 月 21 日至 2021 年 9 月 1 日的数据和之前发表的 2012 年 1 月 1 日至 2012 年 10 月 20 日的数据。收购数据来自 6 个金融数据库、5 个行业新闻媒体和公开的新闻稿。使用线性回归模型比较收购率。结果包括总收购数量、业务类型、地点、供应商详细信息和地理足迹。
结果
在 2019 年 10 月 21 日至 2021 年 9 月 1 日期间，30 家由私人股本支持的平台公司收购了 245 家与 614 个临床地点和 948 名眼科医生或验光师有关的业务。在 30 家平台公司中，有 18 家是我们之前的研究中没有的新公司。在这些收购中，有 127 家是综合性业务，29 家是视网膜业务，89 家是验光业务。从 2012 年到 2021 年，每月收购量每年增加 0.947 次（<0.001*）。德克萨斯州、佛罗里达州、密歇根州和新泽西州是私人股本收购最多的州，分别有 55、48、29 和 28 个诊所收购。2019 年 1 月 1 日至 2 月 29 日（COVID 前）期间，平均每月有 5.71 笔私人股本收购，2020 年 3 月 1 日至 12 月 31 日（COVID 疫苗前[=0.81]）期间，平均每月有 5.30 笔私人股本收购，2021 年 1 月 1 日至 9 月 1 日（COVID 疫苗后[=0.20]）期间，平均每月有 8.78 笔私人股本收购。
结论
在 2012 年至 2021 年期间，随着公司继续采用以地区为重点的收购策略，私人股本收购有所增加。
Zotero 插件